Search Results
Results found for "Ping Chi"
Posts (81)
- Why Sokhom Pin Never Left GPCRs, Even When Everyone Else Did
But Sokhom Pin stayed loyal to GPCRs , even when big pharma turned its gaze to other targets like kinases
- Lab Leadership Without Ego: How Sokhom Pin Built the Happiest Team at Alkermes
At Alkermes , Sokhom Pin wasn’t just leading GPCR programs; he was building culture from the ground up
- Dr. Josephine (Pina) Cardarelli - Dr. GPCR Podcast
Pina Cardarelli, CSO of GPCR Therapeutics.
Other Pages (58)
- Ep 50 with Dr. Thomas P. Sakmar
While a chemistry undergraduate student at the University of Chicago, he attended a NATO Advanced Study Recently, Tom’s lab discovered, along with Yu Chen and Ping Chi , that a mutant of CYSLTR2 is a driver
- Ep 23 with Dr. Qing Fan
Qing Fan About this episode Dr. Qing is a structural biologist interested in the molecular mechanisms controlling how class C GPCRs transmit Join us and learn more about Qing's work and how we powered through a technical issue during the interview Qing Fan on the web Fan Lab Dr. Fan at Columbia University Research Gate LinkedIn Pubmed Dr.
- Ep 60 with Dr. Josephine (Pina) Cardarelli
Josephine (Pina) Cardarelli About Dr. Josephine (Pina) Cardarelli Dr. Pina Cardarelli, CSO for GPCR Therapeutics Inc., based in South Korea, has recently been named President Josephine (Pina) Cardarelli on the web LinkedIn Company Website Dr. GPCR Ecosystem Enjoying the Dr.